Brooks Barnard — Android and Me

I think I’m a pretty healthy guy. I eat well. I exercise. No real serious health problems. But about a half a year ago my life changed in a big way. I had no idea that at the ripe old age of 28 one could be diagnosed with type 1 diabetes, but there I was at the doctors office with a blood glucose level that was through the roof and a no longer working pancreas.

I’m now insulin dependent. Type 1 diabetes can’t be controlled by diet and I need to check my blood sugar levels several times a day and give myself insulin injections to make sure my levels are acceptable. If it goes too low, I run the risk of passing out and dying. If I run too high for long periods of time I run the risk of all sorts of health issues down the line including lost digits and limbs. So as you can see, it’s in my best interest to closely monitor and control my blood sugar levels. In practice, treating type 1 diabetes is a giant balancing act that involves carb counting and needles and any new technologies available could make a huge difference to those affected by the disease.

Read more

The Future of Spage-Age Management, Today! by Mr. Andres Agostini at http://lnkd.in/d7zExFi

This is an excerpt from the conclusion section o, “…The Future of Spage-Age Management, Today!..,” that discusses some management strategies. To read the entire piece, just click the link at the end of article:

BEGINNING OF EXCERPT.

Mr. David Shaw’s question, “…Andres, from your work on the future which management skills need to be developed? Classically the management role is about planning, organizing, leading and controlling. With the changes coming in the future what’s your view on how this management mix needs to change and adapt?…” This question was posited on an Internet Forum, formulated by Mr. David Shaw (Peterborough, United Kingdom) at http://lnkd.in/ba6xX-K on October 09, 2013.

This P.O.V. addresses practical and structural solutions, not onerous quick fixes. THIS P.O.V. WILL BE COMMUNICATED UNAMBIGUOUSLY AND EMPHATICALLY.

Continue reading “The Future of Spage-Age Management, Today!” »

By Michael Molitch-Hou — 3D Printing Industry

The phrase “we want to lower the barrier of entry for brain-computer interfaces” may be the strongest indicator yet that you are, indeed, living in the future. In order to achieve that futuristic dream, Conor Russomanno and Joel Murphy have launched what’s become the infomercial of the 21st Century, a Kickstarter campaign. It’s called OpenBCI and it’s an open-source, 3D printable brain scanner.

OpenBCI is built around a 24-bit analog-to-digital converter called the ADS1299, from Texas Instruments, which measures EEG, as well as EMG (skeletal muscle) and ECG (heart) signals. It’s Arduino compatible, with designs and software all available on GitHub. After printing out the Spider Claw 3000 headset, you can connect the OpenBCI board from the campaign, along with electrodes to attach to your scalp, and begin measuring brain waves for a variety of uses. The software from OpenBCI is compatible with a number of different open source platforms, such as Processing, so that you can take the data and apply it to your own projects. 3D printing makes the OpenBCI even more accessible as it allows users with a variety of head shapes and sizes to print a headset tailored to their own head. Watch the Kickstarter video for a more detailed idea of how the OpenBCI project works:

Read more

Overmanagement by Mr. Andres Agostini

This is an excerpt from the conclusion section o, “…Overmanagement…,” that discusses some management strategies. To read the entire piece, just click the link at the end of article:

BEGINNING OF EXCERPT.

Question: What other contemporary issues particularly concern you? Do you find signs of
hope or resistance around these issues that, perhaps, you finding heartening?

Continue reading “Overmanagement” »

Alzheimer’s disease is on the rise, even as doctors continue to struggle to find potential treatments for it. Researchers expect the number of those suffering from dementia to grow from 44 million at present to three times that by 2050.

The growing number puts increased pressure on researchers to do something to ameliorate the disease. And one drug is attracting the spotlight as it enters clinical trials. Eric Karran, the director of research at Alzheimer’s Research UK, said in a press conference in the lead-up to a G8 summit on dementia that he is “full of hope” that a drug now being tested in the United States on patients with mild dementia may be to Alzheimer’s disease what statins are to heart disease.

Read more

By Lucas Mearian — Computerworld

Computerworld - Approximately 18 people die every day waiting for an organ transplant. But that may change someday sooner than you think — thanks to 3D printing.

Advances in the 3D printing of human tissue have moved fast enough that San Diego-based bio-printing company Organovo now expects to unveil the world’s first printed organ — a human liver — next year.

Like other forms of 3D printing, bio-printing lays down layer after layer of material — in this case, live cells — to form a solid physical entity — in this case, human tissue. The major stumbling block in creating tissue continues to be manufacturing the vascular system needed to provide it with life-sustaining oxygen and nutrients.

Read more

Written By: Cameron Scott — Singularity Hub

Medicine is more an art than a science, doctors are the first to admit, not just because so much remains unknown about the human body, but also because patients often fail to provide relevant details or follow the doctor’s orders. Which explains the strong appeal of digitizing pills so that they register when the patient takes them and including Internet-enabled medical sensors in medical devices.

But how can we safely power electronic technology inside the body? A number of researchers are aggressively seeking answers to that question. For instance, Singularity Hub has covered an electronic pill that, when activated by stomach acid, generates enough power to signal an external device that then registers that the pill has been taken.

Continue reading “Edible Batteries Could Power Smart Pills and Medical Devices” »

By James Gallagher Health and science reporter, BBC News

US scientists have performed a dramatic reversal of the ageing process in animal studies.

They used a chemical to rejuvenate muscle in mice and said it was the equivalent of transforming a 60-year-old’s muscle to that of a 20-year-old — but muscle strength did not improve.

Their study, in the journal Cell, identified an entirely new mechanism of ageing and then reversed it.

Other researchers said it was an “exciting finding”.

Read more

By Jane Wakefield

He knows this because when he had his genetic code read, he found out that he was likely to get age-related macular degeneration (AMD).

The disease leaves the sufferer with a very narrow field of vision.

As head of bio-technology at the world’s most futuristic learning institution, Singularity University, he found the news “burdensome” at first.

Continue reading “Singularity: Reading our genes like computer code” »